Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 1, 2013, Pages 116-125

  Wang, Mengjing ^a   You, Li ^a   Li, Haiming ^a   Lin, Yong ^a   Zhang, Zhijie ^a,b   Hao, Chuanming ^a   Chen, Jing ^a  

^a FUDAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ARTICLE; CLEARANCE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; KIDNEY TUBULE ABSORPTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; NUTRITIONAL STATUS; PHOSPHATE BALANCE; PHOSPHATE EXCRETION; PHOSPHATE INTAKE; PROTEIN INTAKE; URINE VOLUME;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; HOMEOSTASIS; HUMANS; HYPOPHOSPHATEMIA, FAMILIAL; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; LINEAR MODELS; MALE; MIDDLE AGED; MINERALS; MULTIVARIATE ANALYSIS; PHOSPHATES; RENAL DIALYSIS; RISK FACTORS;

EID: 84872193128     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00230112     Document Type: Article

References (49)

1. Tentori F: Mineral and bone disorder and outcomes in hemodialysis patients: Results from the DOPPS. Semin Dial 23: 10-14, 2010
2. Wang AY, Woo J, Sea MM, Law MC, Lui SF, Li PK: Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: What are the implications? Am J Kidney Dis 43: 712-720, 2004
3. Penne EL, van der Weerd NC, Grooteman MP, Mazairac AH, van den Dorpel MA, Nubé MJ, Bots ML, Lévesque R, ter Wee PM, Blankestijn PJ; CONTRAST investigators;: Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients. Clin J Am Soc Nephrol 6: 281-289, 2011
4. Murer H, Hernando N, Forster I, Biber J: Proximal tubular phosphate reabsorption: Molecular mechanisms. Physiol Rev 80: 1373-1409, 2000
5. Russo D, Battaglia Y: Clinical significance of FGF-23 in patients with CKD. Int J Nephrol 2011: 364890, 2011
6. Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M: Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16: 2205-2215, 2005
7. Viaene L, Bammens B, Meijers BK, Vanrenterghem Y, Vanderschueren D, Evenepoel P: Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients. Nephrol Dial Transplant 27: 2017-2022, 2012
8. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y: FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 65: 1943-1946, 2004
9. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
10. Nasrallah MM, El-Shehaby AR, Salem MM, Osman NA, El Sheikh E, Sharaf El Din UA: Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients. Nephrol Dial Transplant 25: 2679-2685, 2010
11. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT; NECOSAD Study Group;: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62: 1046-1053, 2002
12. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4: 1205-1213, 1993
13. Wang M, Li H, Liao H, Yu Y, You L, Zhu J, Huang B, Yuan L, Hao C, Chen J: Phosphate removal model: An observational study of low-flux dialyzers in conventional hemodialysis therapy. Hemodial Int 16: 363-376, 2012
14. Beloosesky Y, Grinblat J, Weiss A, Grosman B, Gafter U, Chagnac A: Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients. Arch Intern Med 163: 803-808, 2003
15. Kuhlmann MK: Management of hyperphosphatemia. Hemodial Int 10: 338-345, 2006
16. Fouque D, Pelletier S, Mafra D, Chauveau P: Nutrition and chronic kidney disease. Kidney Int 80: 348-357, 2011
17. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group;: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15: 1061-1070, 2004
18. Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33: 27-39, 1980
19. Schucker JJ, Ward KE: Hyperphosphatemia and phosphate binders. Am J Health Syst Pharm 62: 2355-2361, 2005
20. Ramirez JA, Emmett M, White MG, Fathi N, Santa Ana CA, Morawski SG, Fordtran JS: The absorption of dietary phosphorus and calcium in hemodialysis patients. Kidney Int 30: 753-759, 1986
21. Cuzick J: A Wilcoxon-type test for trend. Stat Med 4: 87-90, 1985
22. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y: Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 398: 513-518, 2010
23. Yokoyama K, Imura A, Ohkido I, Maruyama Y, Yamazaki Y, Hasegawa H, Urae J, Sekino H, Nabeshima YI, Hosoya T: Serum soluble a-klotho in hemodialysis patients. Clin Nephrol 77: 347-351, 2012
24. Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y: Serum levels of soluble secreted a-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis (published online ahead of print March 29, 2012). Clin Exp Nephrol doi:10.1007/s10157-012-0621-7
25. Semba RD, Cappola AR, Sun K, Bandinelli S, Dalal M, Crasto C, Guralnik JM, Ferrucci L: Plasma klotho and mortality risk in older community-dwelling adults. J Gerontol A Biol Sci Med Sci 66: 794-800, 2011
26. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 20: 381-387, 2009
27. Brener ZZ, Kotanko P, Thijssen S, Winchester JF, Bergman M: Clinical benefit of preserving residual renal function in dialysis patients: An update for clinicians. Am J Med Sci 339: 453-456, 2010
28. Bevington A, Brough D, Baker FE, Hattersley J, Walls J: Metabolic acidosis is a potent stimulus for cellular inorganic phosphate generation in uraemia. Clin Sci (Lond) 88: 405-412, 1995
29. Albalate M, de la Piedra C, Fernández C, Lefort M, Santana H, Hernando P, Hernández J, Caramelo C: Association between phosphate removal and markers of bone turnover in haemodialysis patients. Nephrol Dial Transplant 21: 1626-1632, 2006
30. Pohlmeier R, Vienken J: Phosphate removal and hemodialysis conditions. Kidney Int Suppl 78: S190-S194, 2001
31. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, Sever PS, Poulter NR: Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 375: 895-905, 2010
32. Prié D, Urena Torres P, Friedlander G: Latest findings in phosphate homeostasis. Kidney Int 75: 882-889, 2009
33. Ramon I, Kleynen P, Body JJ, Karmali R: Fibroblast growth factor 23 and its role in phosphate homeostasis. Eur J Endocrinol 162: 1-10, 2010
34. Zhang Q, Qiu J, Li H, Lu Y, Wang X, Yang J, Wang S, Zhang L, Gu Y, Hao CM, Chen J: Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD. J Am Soc Nephrol 22: 664-672, 2011
35. Lu Y, Feng JQ: FGF23 in skeletal modeling and remodeling. Curr Osteoporos Rep 9: 103-108, 2011
36. Llach F: Parathyroidectomy in chronic renal failure: Indications, surgical approach and the use of calcitriol. Kidney Int Suppl 29: S62-S68, 1990
37. Li H, Long Q, Shao C, Fan H, Yuan L, Huang B, Gu Y, Lin S, Hao C, Chen J: Effect of short-term low-protein diet supplemented with keto acids on hyperphosphatemia in maintenance hemodialysis patients. Blood Purif 31: 33-40, 2011
38. Kopple JD: National Kidney Foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 37(Suppl 2): S66-S70, 2001
39. Nakao T, Matsumoto H, Okada T, Kanazawa Y, Yoshino M, Nagaoka Y, Takeguchi F: Nutritional management of dialysis patients: Balancing among nutrient intake, dialysis dose, and nutritional status. Am J Kidney Dis 41(Suppl 1): S133-S136, 2003
40. Lindsay R, Coutts JR, Hart DM: The effect of endogenous oestrogen on plasma and urinary calcium and phosphate in oophorectomized women. Clin Endocrinol (Oxf) 6: 87-93, 1977
41. Krassas GE, Papadopoulou P: Oestrogen action on bone cells. J Musculoskelet Neuronal Interact 2: 143-151, 2001
42. Uemura H, Irahara M, Yoneda N, Yasui T, Genjida K, Miyamoto KI, Aono T, Takeda E: Close correlation between estrogen treatment and renal phosphate reabsorption capacity. J Clin Endocrinol Metab 85: 1215-1219, 2000
43. Slatopolsky E: The intact nephron hypothesis: The concept and its implications for phosphate management in CKD-related mineral and bone disorder. Kidney Int Suppl 79: S3-S8, 2011
44. Bagga A, Bajpai A, Menon S: Approach to renal tubular disorders. Indian J Pediatr 72: 771-776, 2005
45. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R: Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19: 1379-1388, 2008
46. Kuro-o M: Phosphate and Klotho. Kidney Int 79(Suppl 121): S20-S23, 2011
47. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M, Moe OW: Klotho: A novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24: 3438-3450, 2010
48. Razzaque MS: FGF23-mediated regulation of systemic phosphate homeostasis: Is Klotho an essential player? Am J Physiol Renal Physiol 296: F470-F476, 2009
49. Marks J, Debnam ES, Unwin RJ: Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol 299: F285-F296, 2010